A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis

NCT01834807 ·Status: COMPLETED

A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece

NCT01086033 ·Status: COMPLETED

Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis

NCT01076205 ·Status: COMPLETED

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

NCT01273519 ·Status: COMPLETED

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01078090 ·Status: COMPLETED

Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

NCT01078610 ·Status: WITHDRAWN

A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

NCT01705730 ·Status: COMPLETED

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

NCT00234897 ·Status: COMPLETED ·Phase: PHASE4

Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs

NCT01083693 ·Status: COMPLETED

Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

NCT01079182 ·Status: COMPLETED

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

NCT01346488 ·Status: COMPLETED

A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis

NCT01921478 ·Status: COMPLETED

Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis

NCT01078571 ·Status: COMPLETED

Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA

NCT01117480 ·Status: COMPLETED

Optimization of Treatment With Adalimumab (Humira)

NCT01585064 ·Status: COMPLETED

Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients

NCT03339102 ·Status: COMPLETED

A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis

NCT00963313 ·Status: COMPLETED

Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab

NCT01752855 ·Status: COMPLETED ·Phase: PHASE2

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

NCT01329380 ·Status: COMPLETED

Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis

NCT01076959 ·Status: COMPLETED

RESTART C0168Z05 Rheumatoid Arthritis Study

NCT00714493 ·Status: COMPLETED ·Phase: PHASE4

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

NCT02137226 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385 ·Status: COMPLETED ·Phase: PHASE3

Observation of Treatment With Certolizumab Pegol in Daily Practice

NCT01069419 ·Status: COMPLETED

Efficacy of Humira in Behcet Patients With Arthritis

NCT01497717 ·Status: COMPLETED ·Phase: PHASE3